Learning @ ISTM
Rabies Update: New Strategies for Travellers
Recorded On: 05/04/2022
- Non-Member - $70
- 5 Year Healthcare Professionals (Medical Doctor, Physician) - Free!
- 5 Year Healthcare Professionals (Nurse, Nurse Practitioner, Physician's Assistant, Pharmacist, Paramedic, Researchers) - Free!
- 1 Year Healthcare Professionals (Medical Doctor, Physician) - Free!
- LMIC Healthcare Professional Membership - Free!
- Retiree Membership - Free!
- 1 Year Healthcare Professionals (Nurse, Nurse Practitioner, Physician's Assistant, Pharmacist, Paramedic, Researchers) - Free!
- Student Membership (Non-degreed/Non-licensed) - Free!
- Staff - Free!
Title: Rabies Update: New Strategies for Travellers
Date: Wednesday, 04 May 2022
Time: 10.00 AM EDT UTC-04
To check your time zone, go to the time and date website: Here
Registration Fee: Complimentary to members; $70 USD for non-members
You must register to attend the webinar.
Rabies, an almost invariably fatal disease, is estimated to cause at least 59,000 human deaths annually in over 150 countries, with 95% of cases occurring in Africa and Asia. Almost all of rabies cases are dog-mediated, with approximately half of cases occurring in children under 15.
For travellers who sustain a bite from a potentially rabid animal, anxiety and trip disruptions can ensue. Albeit rare in travellers, rabies have catastrophic consequences.
The cost of pre-exposure prophylaxis has been a major barrier to vaccine acceptance, so abbreviated schedules recently approved by the World Health Organisation (WHO) and the Advisory Committee on Immunization Practices (ACIP) may be a strategy to increase vaccine acceptance.
PEC Chair: Sarah Kohl, MD
PEC Co-Chair: Yen Bui, MD, DTMH
Moderator: Prativa Pandey, MD
Agam Rao, MD
David Shlim, MD
Leo Visser, MD, PhD
By the end of this webinar, the attendee should be able to:
• Summarize the latest recommendations from WHO and ACIP
• Discuss rabies prevention from a Travel Medicine perspective
• Describe new products in development (vaccines, monoclonal antibodies)
Who Should Attend:
• Infectious Disease Practitioners – Doctors, Nurses, and Pharmacists
• Travel Health Practitioners – Doctors, Nurses, and Pharmacists
• Occupational Health Practitioners
• Public Health Practitioners
• Family Medicine Practitioners
• Any others who care for travelers and workers who might be exposed to rabies
Sarah Kohl, MD
Chair, Professional Education Committee
UPMC Children's Hospital of Pittsburgh
Sarah Kohl, MD is a Clinical Assistant Professor of Pediatrics at the University of Pittsburgh Medical School, USA. As a practicing general pediatrician, she applies epidemiologic principles to improve the health of her patients. She is Chair of the ISTM Professional Education Committee, a Fellow of the American Academy of Pediatrics and holds a Certificate in Travel Health.
Yen Bui, MD, DTMH
Professional Education Committee, Co-Chair
Department of Public Health, Quebec
Dr. Bui has been working for the last 20 years as a Travel Health Consultant for the Department of Public Health of the Montérégie, Canada, where she provides advice and updates to Travel Health professionals. Her certifications include CTH® and CTropMed®. Dr Bui is one of the coauthors of the Quebec Immunization Protocol, as well as a member of the Quebec Advisory Committee on Travel Health, the Committee to Advise on Tropical Medicine and Travel, Canada, and the Working Group on Yellow Fever Vaccine.
Prativa Pandey, MD (Moderator)
Medical Director, CIWEC Hospital and Travel Medicine center
Founding President Nepal Travel Medicine Society
Dr. Pandey was born in Nepal and obtained her medical degree in New Delhi, India. She did her residency training in Internal Medicine in Boston, USA and returned to Nepal after working for 10
years in the Boston area.
In Nepal, she joined the CIWEC Clinic and Travel Medicine Center, the oldest Travel Medicine Center in a developing country that had a rich tradition of research in travel associated illnesses under the leadership of Dr David R. Shlim. The CIWEC Clinic evolved into a hospital and Dr Pandey became the medical director of CIWEC hospital in 1998.
She was elected a counselor of the International Society of Travel Medicine (ISTM) in 2003 and served as the President of the ISTM from 2005-2007. She is the founding President of Nepal Society of Travel Medicine. She opened the first Travel Medicine Center in Pokhara, Nepal in 2014. She served one season at the Himalayan Rescue Association (HRA) aid-post as a volunteer doctor at Pheriche near Everest base camp and currently serves on the medical advisory board of the HRA.
CIWEC Hospital has participated in the global surveillance network called GeoSentinel since 1998 and Dr. Pandey has been the site director or co-site director for this project. Her publications include Traveler's Diarrhea - etiology and resistance, Altitude Illness, Pulmonary Embolism at high altitude, a novel treatment for Frostbite, in addition to other Travel Medicine related topics.
Agam Rao, MD
U.S. Centers for Disease Control and Prevention’s Division of High Consequence Pathogens and Pathology
Dr. Agam Rao is a physician with the U.S. Centers for Disease Control and Prevention’s Division of High Consequence Pathogens and Pathology. She is board certified in infectious diseases and is a Captain in the Commissioned Corps of the U.S. Public Health Service. Dr. Rao’s areas of public health expertise include developing national guidelines (e.g., recommendations of the U.S. Advisory Committee on Immunization Practices); characterizing clinical features of high consequence pathogens (i.e., rabies, poxviruses, and botulism); and investigating, both domestical and international outbreaks of infections.
David Shlim, MD
Medical Director, Jackson Hole Travel and Tropical Medicine; Medical Editor, Health Information for International Travel (The Yellow Book)
Chairman, The Medicine and Compassion Project, Jackson Hole, Wyoming
Dr. Shlim is the author of over fifty-five original research papers and has written over twenty chapters in textbooks on travel medicine. He is an editor of the CDC’s Health Information for International Travel, and a co-author of the chapter on rabies in that book. He is a past president of the International Society of Travel Medicine, and the current chairman of The Medicine and Compassion Projectâ.
He pioneered travel medicine research on travelers’ diarrhea, typhoid fever, hepatitis, altitude illness, trekking deaths, and rabies. He also helped discover the diarrhea causing protozoal pathogen Cyclospora.
Dr. Shlim is the co-author, with Chokyi Nyima Rinpoche, of Medicine and Compassion, a book that offers advice from a Tibetan Buddhist lama on methods of training in compassion for health care professionals. His new memoir, A Gentle Rain of Compassion, will be published in September 2022.
Prof Leo G. Visser, MD, PhD
Infectious Diseases and LUMC travel clinic, Department Head
Leiden University Medical Center
Professor Leo Visser studied medicine at the University of Leuven in Belgium. He specialized in Infectious Diseases at the Leiden University Medical Center, where he obtained his PhD (1997). He was appointed as Professor in Infectious Diseases and Travel Medicine in 2014.
For many years, Professor Visser is involved in clinical care, research, teaching and training in internal medicine and infectious diseases, with the emphasis on vaccinology, vaccine-preventable and tropical infectious diseases, travel medicine and global health.
Professor Visser holds a position as Head of the Department of Infectious Diseases and LUMC travel clinic at the LUMC. The travel clinic is member of the Leiden Vaccine Group and is a centre of expertise for travel medicine and vaccination research in The Netherlands.
Professor Visser holds several positions at national and international committees and scientific organizations. Currently, Professor Visser is member of the European Expert Committee for Travel Medicine. In the past he was, amongst others, member of the steering committee of the European Network on the Surveillance of Imported Infectious Diseases (www.tropnet.eu), chair of the National Coordination Centre for Travellers' Health Advice (LCR), and President of the International Society of Travel Medicine.
His current research activities involve the safety and immunogenicity of alternative vaccination routes and vaccine responses in the more vulnerable individual with chronic diseases, advanced age, or immunosuppressed in particular those following solid organ transplantation or receiving immunobiologicals.